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Carolina Herrera. Classic beauty — demure smoky eyes and a romantic 
updo — was expected for Herrera's last show before stepping down from her 
namesake brand. Terracotta color of lipstick in fashion in 2018 very favorably 
emphasizes the skin of persons. 
For the Oscar de la Renta show. Tom Pecheux created a subtly glimmery 
effect, layering violet cream shadow over models' lids before blossoming pink-
and-purple-tinged glitter over top. In addition to placing it on the upper lids, he 
also intentionally dabbed a bit on the lower lash line, concentrated at the center, 
to embrace the inevitable fallout. 
The brightest trends in makeup in 2018 that were presented at the Milan Fashion 
Week were smoky eye, redliner, graphic eyeshadow, flawless skin.  
Thus, runway make-up embody freedom of imagination. When an image is created, 
artist can not think about the framework of society and some canons of beauty. 
Therefore, in the creation of an ideal show stylists and makeup artists play an important 
role and they should work in close tandem with designers, so that in the future, the 
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THE HPLC METHOD FOR THE ANALYSIS OF SIROLIMUS 
IN DRUG PRODUCTS 
Antibiotic is one of the most important commercially exploited secondary 
metabolites produced by bacteria, fungi and Streptomyces and employed in a wide 
range. Most of the antibiotics used today are from the microbes. [2] 
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The aim of this study was to research a simple, rapid and sensitive reverse phase 
high performance liquid chromatography (RP-HPLC) method for quantification of 
sirolimus (SRL) in pharmaceutical dosage forms. 
Sirolimus (SRL, formerly rapamycin: C51H79NO13, CAS: 53123-88-9) is a 
lactone-lactam macrolide antibiotic with immunosuppressant and anticancer effects. 
It was first identified as an antifungal agent produced by the Streptomyces 
hygroscopicus bacterium and was subsequently demonstrated to be a potent 
immunosuppressive agent that was approved by the U.S. Food and Drug 
Administration (FDA) to be used beside cyclosporine or tacrolimus in kidney 
transplantation. In contrast to tacrolimus and cyclosporine, which inhibit the 
production of cytokines, sirolimus binds to the FK (peptidyl-prolyl cis-trans 
isomerase) binding protein which modulates the activity of the mammalian Target of 
Rapamycin (mTOR). The mTOR inhibits Interleukin-2-mediated signal transduction, 
resulting in cell cycle stop in the G1-S phase and prevents cell cycle progression and 
proliferation, hence blocks the response of T- and B-cell activation by cytokines. [4] 
These pharmacological properties allow rapamycin not only to be a promising 
immunosuppressant with the absence of nephrotoxicity but also to be a possible 
chemotherapeutic agent against many types of solid tumor. SRL is a white to 
off-white powder, insoluble in water, very slightly soluble in hexane and petroleum 
ether, soluble in methanol, diethyl ether, and N, N-dimethylformamide (DMF) and 
freely soluble in benzyl alcohol, chloroform, acetone, and acetonitrile (ACN). [1] 
Validation of new analytical methods for pharmaceutical products is a requirement of 
Current Good Manufacturing Practice (cGMP) regulations. As stated by the current 
International Conference on Harmonization (ICH) guideline, accuracy, precision, 
linearity and stability of test methods are some of the analytical parameters which 
require assays validation. [3] Several types of analytical methods have been used for 
quantification of SRL, including immunoassay, HPLC ultraviolet, and HPLC mass 
spectrometric detection (HPLC-MS or HPLC/MS/ MS). The immunoassay is not 
commercially available, and there is an acute need for an accurate, rapid, and simple 
chromatographic assay to determine SRL in drug development procedure and also 
Збірник тез доповідей ІII Всеукраїнської науково-практичної конференції «Інноваційні тенденції 
підготовки фахівців в умовах полікультурного та мультилінгвального глобалізованого світу»  
 
275 
post marketing investigations. Considering the less complication and readily 
availability of HPLC-UV method in research laboratories and clinic a simple and 
rapid chromatographic method in the present study was developed to routine analysis 
of sirolimus concentration. 
Conclusion: Therefore the rapid and sensitive developed method can be used 
for the routine analysis of sirolimus such as dissolution and stability assays of pre- 
and post-marketed dosage forms. The analytical method described in this paper has 
good accuracy, precision, linearity and is suitable for SRL assay. As the method was 
successfully validated based on ICH guidelines, it can be readily used in quality 
control laboratories for the routine pharmaceutical analysis. Also this simple and 
rapid method can simplify performance in developing new formulations. Further 
investigations are necessary to adopt this method to protein binding analysis and 
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